「1%by」の検索結果
112件:16~20件目を表示
-

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
http://www.senju.co.jp/english/rd/trial.html -

Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju
http://www.senju.co.jp/english/about/philosophy.html -

General Announcement: Nov 26, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf -

NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines New Mytear® A Supplies moisture. CHARACTERISTICS This is an artificial tear-type eye drop with mild sensation. It supplies the moisture of tears that is important to the eyes
http://www.senju.co.jp/english/products/myteara.html -

MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
https://www.senju.co.jp/english/products/mytearv.html